Canada markets closed

CareDx, Inc (CDNA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
23.68-0.35 (-1.46%)
At close: 04:00PM EDT
23.70 +0.02 (+0.08%)
After hours: 07:25PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close24.03
Open24.23
Bid23.66 x 1200
Ask24.02 x 900
Day's Range23.14 - 24.64
52 Week Range19.34 - 96.88
Volume1,147,735
Avg. Volume933,174
Market Cap1.26B
Beta (5Y Monthly)0.81
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    CareDx The Transplant Company Releases Inaugural Environmental, Social and Governance Report

    SOUTH SAN FRANCISCO, Calif., June 21, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the release of its first environmental, social and governance (ESG) report.

  • Business Wire

    CareDx To Participate in Upcoming Jefferies Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., June 02, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the Jefferies Healthcare Conference on June 9th, 2022.

  • Business Wire

    CareDx Leads Transplant Innovation with AiKidney, an AI Clinical Decision Support Tool for Predicting Allograft Rejection Risk

    SOUTH SAN FRANCISCO, Calif., June 02, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it plans to expand its growing multimodality portfolio with AiKidney™, a new allograft risk assessment clinical decision support tool, in development, that includes AlloSure® and other transplant metrics.